We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+29%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.1B
AUM Growth
+$1.94B
Cap. Flow
-$956M
Cap. Flow %
-6.31%
Top 10 Hldgs %
19.25%
Holding
1,647
New
467
Increased
323
Reduced
312
Closed
527

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$208M
2
JNJ icon
Johnson & Johnson
JNJ
+$190M
3
PFE icon
Pfizer
PFE
+$166M
4
NVDA icon
NVIDIA
NVDA
+$154M
5
ADBE icon
Adobe
ADBE
+$134M

Sector Composition

Rank Sector Weight
1 Healthcare 27.79%
2 Technology 18.34%
3 Consumer Discretionary 12.92%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDD icon
801
Pinduoduo
PDD
$132B
$839K 0.01%
+9,779
New +$588K
LTC
802
LTC Properties
LTC
$2.12B
$835K 0.01%
22,157
+16,969
+327% +$604K
VECO icon
803
Veeco
VECO
$3.02B
$834K 0.01%
61,760
+23,070
+60% +$265K
CIEN icon
804
Ciena
CIEN
$54.9B
$828K 0.01%
15,284
-178,924
-92% -$8.89M
USCR
805
DELISTED
U S Concrete, Inc.
USCR
$828K 0.01%
33,379
+13,278
+66% +$266K
BKE icon
806
Buckle
BKE
$2.4B
$827K 0.01%
52,782
+48,368
+1,096% +$725K
VISN
807
Vistance Networks Inc
VISN
$2.63B
$827K 0.01%
+99,224
New +$980K
TECK icon
808
Teck Resources
TECK
$32.8B
$820K 0.01%
+78,485
New +$721K
MREO
809
Mereo BioPharma
MREO
$43.5M
$818K 0.01%
+267,180
New +$471K
PRDO icon
810
Perdoceo Education
PRDO
$1.97B
$817K 0.01%
51,272
-218,235
-81% -$3.12M
PRK icon
811
Park National Corp
PRK
$3.63B
$815K 0.01%
+11,568
New +$846K
GEF icon
812
Greif
GEF
$4.97B
$813K 0.01%
+23,602
New +$775K
LBTYK icon
813
Liberty Global Class C
LBTYK
$3.41B
$810K 0.01%
+37,626
New +$751K
HASI icon
814
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.18B
$809K 0.01%
28,480
-70,472
-71% -$1.93M
MMSI icon
815
Merit Medical Systems
MMSI
$5.36B
$808K 0.01%
+17,709
New +$715K
TPB icon
816
Turning Point Brands
TPB
$1.79B
$806K 0.01%
32,336
AXDX
817
DELISTED
Accelerate Diagnostics
AXDX
$799K 0.01%
5,266
+4,030
+326% +$397K
HLT icon
818
Hilton Worldwide
HLT
$70B
$799K 0.01%
10,880
+8,880
+444% +$659K
CXT icon
819
Crane NXT
CXT
$2.96B
$798K 0.01%
38,694
+38,406
+13,335% +$718K
SSB icon
820
SouthState Bank Corp
SSB
$10.5B
$798K 0.01%
16,732
-9,508
-36% -$497K
SCL icon
821
Stepan Co
SCL
$1.47B
$797K 0.01%
+8,213
New +$772K
SVC
822
Service Properties Trust
SVC
$1.05B
$797K 0.01%
+22,479
New +$783K
HZO icon
823
MarineMax
HZO
$1.15B
$796K 0.01%
35,515
-33,466
-49% -$550K
WGO icon
824
Winnebago Industries
WGO
$906M
$796K 0.01%
+11,948
New +$610K
DOMO icon
825
Domo
DOMO
$189M
$786K 0.01%
+24,447
New +$544K

Similar funds

Marshall Wace North America's Q2 2020 Portfolio in Review

As of Q2 2020, Marshall Wace North America held 1,647 positions worth $15.1B, up 15% from $13.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America withdrew a net $956M in Q2 2020, closing 527 positions and reducing 312 holdings. Its most notable exit was Becton Dickinson, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Motorola Solutions worth $88.4M.

  • Marshall Wace North America's largest Q2 2020 buy was Motorola Solutions: 630,587 shares worth $88.4M.
  • Marshall Wace North America added most to JPMorgan Chase in Q2 2020, an estimated $148M increase.
  • Marshall Wace North America's biggest Q2 2020 reduction was Merck, cutting an estimated $208M.
  • Marshall Wace North America fully exited Becton Dickinson in Q2 2020, selling an estimated $86.4M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $15.1B portfolio in Q2 2020.
  • Marshall Wace North America opened 467 new positions and closed 527 in Q2 2020.
  • Marshall Wace North America's portfolio value rose 15% quarter-over-quarter to $15.1B.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.